Cargando…
Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate
INTRODUCTION: This study was aimed at characterizing basal and adrenocorticotropic hormone (ACTH)-induced steroidogenesis in sepsis and nonsepsis patients with a suspicion of critical illness-related corticosteroid insufficiency (CIRCI), taking the use of etomidate-inhibiting 11β-hydroxylase into ac...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580698/ https://www.ncbi.nlm.nih.gov/pubmed/22781364 http://dx.doi.org/10.1186/cc11415 |
_version_ | 1782260310389817344 |
---|---|
author | Molenaar, Nienke Bijkerk, Ronald M Beishuizen, Albertus Hempen, Christel M de Jong, Margriet FC Vermes, Istvan van der Sluijs Veer, Gertjan Girbes, Armand RJ Groeneveld, AB Johan |
author_facet | Molenaar, Nienke Bijkerk, Ronald M Beishuizen, Albertus Hempen, Christel M de Jong, Margriet FC Vermes, Istvan van der Sluijs Veer, Gertjan Girbes, Armand RJ Groeneveld, AB Johan |
author_sort | Molenaar, Nienke |
collection | PubMed |
description | INTRODUCTION: This study was aimed at characterizing basal and adrenocorticotropic hormone (ACTH)-induced steroidogenesis in sepsis and nonsepsis patients with a suspicion of critical illness-related corticosteroid insufficiency (CIRCI), taking the use of etomidate-inhibiting 11β-hydroxylase into account. METHOD: This was a prospective study in a mixed surgical/medical intensive care unit (ICU) of a university hospital. The patients were 62 critically ill patients with a clinical suspicion of CIRCI. The patients underwent a 250-μg ACTH test (n = 67). ACTH, adrenal steroids, substrates, and precursors (modified tandem mass spectrometry) also were measured. Clinical characteristics including use of etomidate to facilitate intubation (n = 14 within 72 hours of ACTH testing) were recorded. RESULTS: At the time of ACTH testing, patients had septic (n = 43) or nonseptic critical illness (n = 24). Baseline cortisol directly related to sepsis and endogenous ACTH, independent of etomidate use. Etomidate was associated with a lower baseline cortisol and cortisol/11β-deoxycortisol ratio as well as higher 11β-deoxycortisol, reflecting greater 11β-hydroxylase inhibition in nonsepsis than in sepsis. Cortisol increases < 250 mM in exogenous ACTH were associated with relatively low baseline (HDL-) cholesterol, and high endogenous ACTH with low cortisol/ACTH ratio, independent of etomidate. Although cortisol increases with exogenous ACTH, levels were lower in sepsis than in nonsepsis patients, and etomidate was associated with diminished increases in cortisol with exogenous ACTH, so that its use increased, albeit nonsignificantly, low cortisol increases to exogenous ACTH from 38% to 57%, in both conditions. CONCLUSIONS: A single dose of etomidate may attenuate stimulated more than basal cortisol synthesis. However, it may only partly contribute, particularly in the stressed sepsis patient, to the adrenal dysfunction of CIRCI, in addition to substrate deficiency. |
format | Online Article Text |
id | pubmed-3580698 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35806982013-02-26 Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate Molenaar, Nienke Bijkerk, Ronald M Beishuizen, Albertus Hempen, Christel M de Jong, Margriet FC Vermes, Istvan van der Sluijs Veer, Gertjan Girbes, Armand RJ Groeneveld, AB Johan Crit Care Research INTRODUCTION: This study was aimed at characterizing basal and adrenocorticotropic hormone (ACTH)-induced steroidogenesis in sepsis and nonsepsis patients with a suspicion of critical illness-related corticosteroid insufficiency (CIRCI), taking the use of etomidate-inhibiting 11β-hydroxylase into account. METHOD: This was a prospective study in a mixed surgical/medical intensive care unit (ICU) of a university hospital. The patients were 62 critically ill patients with a clinical suspicion of CIRCI. The patients underwent a 250-μg ACTH test (n = 67). ACTH, adrenal steroids, substrates, and precursors (modified tandem mass spectrometry) also were measured. Clinical characteristics including use of etomidate to facilitate intubation (n = 14 within 72 hours of ACTH testing) were recorded. RESULTS: At the time of ACTH testing, patients had septic (n = 43) or nonseptic critical illness (n = 24). Baseline cortisol directly related to sepsis and endogenous ACTH, independent of etomidate use. Etomidate was associated with a lower baseline cortisol and cortisol/11β-deoxycortisol ratio as well as higher 11β-deoxycortisol, reflecting greater 11β-hydroxylase inhibition in nonsepsis than in sepsis. Cortisol increases < 250 mM in exogenous ACTH were associated with relatively low baseline (HDL-) cholesterol, and high endogenous ACTH with low cortisol/ACTH ratio, independent of etomidate. Although cortisol increases with exogenous ACTH, levels were lower in sepsis than in nonsepsis patients, and etomidate was associated with diminished increases in cortisol with exogenous ACTH, so that its use increased, albeit nonsignificantly, low cortisol increases to exogenous ACTH from 38% to 57%, in both conditions. CONCLUSIONS: A single dose of etomidate may attenuate stimulated more than basal cortisol synthesis. However, it may only partly contribute, particularly in the stressed sepsis patient, to the adrenal dysfunction of CIRCI, in addition to substrate deficiency. BioMed Central 2012 2012-07-10 /pmc/articles/PMC3580698/ /pubmed/22781364 http://dx.doi.org/10.1186/cc11415 Text en Copyright ©2012 Molenaar et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Molenaar, Nienke Bijkerk, Ronald M Beishuizen, Albertus Hempen, Christel M de Jong, Margriet FC Vermes, Istvan van der Sluijs Veer, Gertjan Girbes, Armand RJ Groeneveld, AB Johan Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate |
title | Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate |
title_full | Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate |
title_fullStr | Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate |
title_full_unstemmed | Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate |
title_short | Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate |
title_sort | steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580698/ https://www.ncbi.nlm.nih.gov/pubmed/22781364 http://dx.doi.org/10.1186/cc11415 |
work_keys_str_mv | AT molenaarnienke steroidogenesisintheadrenaldysfunctionofcriticalillnessimpactofetomidate AT bijkerkronaldm steroidogenesisintheadrenaldysfunctionofcriticalillnessimpactofetomidate AT beishuizenalbertus steroidogenesisintheadrenaldysfunctionofcriticalillnessimpactofetomidate AT hempenchristelm steroidogenesisintheadrenaldysfunctionofcriticalillnessimpactofetomidate AT dejongmargrietfc steroidogenesisintheadrenaldysfunctionofcriticalillnessimpactofetomidate AT vermesistvan steroidogenesisintheadrenaldysfunctionofcriticalillnessimpactofetomidate AT vandersluijsveergertjan steroidogenesisintheadrenaldysfunctionofcriticalillnessimpactofetomidate AT girbesarmandrj steroidogenesisintheadrenaldysfunctionofcriticalillnessimpactofetomidate AT groeneveldabjohan steroidogenesisintheadrenaldysfunctionofcriticalillnessimpactofetomidate |